Perrigo Wary Of ‘Destroying’ Value Through Premature Sale

As Covid-19 ProAir Impact Revealed In First Quarter

 
• By Dean Rudge
  
Clock_Nail
Perrigo will not hurry into an immediate transaction for its Prescription US generics unit • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business